Why the study?
Does intensive lipid-lowering therapy halt the progression or induce regression of calcific aortic stenosis in patients with this condition?
Does intensive lipid-lowering therapy halt the progression or induce regression of calcific aortic stenosis in patients with this condition?
Intensive lipid-lowering therapy does not appear to halt progression or induce regression of calcific aortic stenosis, though small benefits or reductions in clinical endpoints cannot be excluded.
No role for intensive lipid-lowering in calcific aortic stenosis; reinforces consensus against its use to modify valve progression.
Intensive lipid-lowering therapy does not halt the progression of calcific aortic stenosis or induce its regression. This study cannot exclude a small reduction in the rate of disease progression or a significant reduction in major clinical end points. Long-term, large-scale, randomized, controlled trials are needed to establish the role of statin therapy in patients with calcific aortic stenosis.
No takes yet. Share an insight, caveat, or question.
Cowell et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: